Condition
Sciatica Acute
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 3 (1)
P 4 (1)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06157177Phase 4RecruitingPrimary
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
NCT07397117Not ApplicableRecruitingPrimary
Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care
NCT07588126Not ApplicableCompletedPrimary
Ultrasound-guided Transgluteal Sciatic Nerve Hydrodissection for the Treatment of Sciatica in the Emergency Department
NCT07161323Not ApplicableRecruiting
SNAG and SNME in Non-Specific Sciatic Pain
NCT05626140Phase 3CompletedPrimary
COMPARISON OF EFFICACY OF DIFFERENT DRUG COMBINATIONS IN ACUTE SCIATICA
Showing all 5 trials